CytoDyn auditor MGO declines re-election for FY2024; no accounting disagreements

CytoDyn Inc.

MGO declined to stand for re-election as CytoDyn's independent auditor for fiscal year 2024 on Sept 19, 2023.
MGO's audit reports for FY2022 and FY2023 contained no adverse opinion but expressed substantial going-concern doubt.
No disagreements on accounting principles or practices between CytoDyn and MGO during the two most recent fiscal years.
Material weaknesses in internal control reported for FY2022 were remediated; controls effective as of FY2023.
Audit committee is in the process of selecting a new registered public accounting firm.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.